Captrust Financial Advisors Compugen LTD Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$1.57 - $3.33 $3,493 - $7,409	2,225 New	2,225 $4,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $8,180 - $14,320	-2,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.87 - $9.16 $13,740 - $18,320	2,000 New	2,000 $17,000
Q4 2019 Feb 14, 2020	SELL	$3.9 - $6.16 $18,138 - $28,650	-4,651 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.35 - $4.19 $10,929 - $19,487	4,651 New	4,651 $19,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.